CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 52 enrolled
Drug / intervention
Lipitor 20Mg Tablet +3 moredrug
Likely dose
Lipitor 20Mg Tabletfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03360916
NCT03360916Phase 4Completed
CompareCT.gov

Impact of Statin Therapy on Adaptations to Aerobic Exercise

University of Kansas Medical Center·interventional·Posted Dec 4, 2017·Updated Apr 15, 2025

In Brief

A Phase 4 clinical trial evaluating Lipitor 20Mg Tablet, Lipitor 80Mg Tablet, and 2 other interventions for Cardiovascular Diseases. Completed, enrolled 52 participants across 1 site.

Detailed Summary

The purpose of this study is to determine how different doses of a statin affect muscle health and exercise.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases
CountriesUnited States
CollaboratorsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedDec 4, 2017
Enrollment StartFeb 1, 2018
Primary CompletionJun 5, 2024
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 8.6 years ago

Interventions

Lipitor 20Mg Tabletdrug

One tablet by mouth every day for 12 weeks.

Lipitor 80Mg Tabletdrug

One tablet by mouth every day for 12 weeks.

Placebodrug

One matching placebo tablet by mouth every day for 12 weeks.

Exercise Programbehavioral

Exercise program of brisk walking and/or slow jogging on a treadmill for 90 minutes of exercise spread over 3 days during week 1, 150 minutes of exercise spread over 5 days during week 2, 225 minutes of exercise over 5 days during week 3 and for the rest of the study.